Microcurrent Stimulation to Treat Macular Degeneration

Completed

Conditions studied: Retinal Diseases, Stargardt's Disease, Retinitis Pigmentosa

In brief

Microcurrent stimulation thereapy improves retinal efficiency and may restore and/or improve retinal function.

Key facts

Study ID

NCT01790958

Run by

Retina Institute of Hawaii

People needed

50

Starts

2012-06-01

Expected to finish

2012-12-01

Last updated by the study team

2013-02-13

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Ability to provide written consent and comply with follow up visits
• Age 40 years or older
• ETDRS best corrected visual acuity better than 5 letters
• History of Dry Age Relted Macular Degeneration; Retinitis Pigmentosa; Stargardt's disease
• No Anti-VEGF treatments for at least 3 months prior to study
• No new antioxidant/vitamin supplementation for at least 3 months prior to study

You may not qualify if…

• History of Non-Compliance with regular medical visits
• Significant media opacities (exclude NS 4+) that may interfere with assessing visual acuity
• Presence of pigment epithelial tears or rips
• Known serious allergies to fluorescein dye
• Presence of retinal neovascularization
• Any treatment with an investigation agent in the past 30 days

Where it is running

• Hawaii Cataract Laser Institute - Hilo — Hilo, Hawaii, United States
• Retina Institute of Hawaii — Honolulu, Hawaii, United States
• Hawaii Cataract Laser Institute - Maui — Kahului, Hawaii, United States
• Hawaii Cataract Laser Institute - Kona — Kailua-Kona, Hawaii, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.